Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Concert Pharmaceuticals Inc

TRADE

NASDAQ: CNCEHealthcare / Biotechnology / USA
16.61-0.02-0.12%Vol 65 0751Y Perf 16.33%
Jul 19th, 2018 16:00
BID13.00 ASK27.71
Open16.57 Previous Close16.63
Pre-Market- After-Trading16.61
 - -%  - -%
Target Price
26.67 
Analyst Rating
Strong Buy 1.00
Potencial %
60.57 
Finscreener Ranking
★★★★★     75.97
Insiders Trans % 3/6/12M
-100/-100/-76 
Value Ranking
★★★★★     80.30
Insiders Value % 3/6/12M
-100/-100/28 
Growth Ranking
★★★★★     83.49
Insiders Shares Cnt. % 3/6/12M
-100/-100/38 
Income Ranking
 —    -
Market Cap (mil)389 
Earnings Rating
Price Range Ratio 52wk %
17.74 
Earnings Date
14th Aug 2018

Today's Price Range

16.4516.80

 

52wk Range

13.5730.71

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-17.24%
3 Months
-13.31%
6 Months
-15.30%
1 Year
16.33%
3 Years
-2.92%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CNCE16.61-0.0200-0.12
AAPL191.881.48000.78
GOOG1 186.96-8.9200-0.75
MSFT104.40-0.7200-0.68
XOM82.01-0.2100-0.26
WFC56.33-0.2400-0.42
JNJ125.94-1.8600-1.46
FB208.09-1.2700-0.61
GE13.73-0.0200-0.15
JPM109.89-1.6400-1.47
...

TickerPriceChg.%52 Week High
SNA173.299.50185.47
DOV78.125.3088.11
DHR103.204.47106.08
SCG40.203.5368.35
SWN5.363.476.72
WMB28.693.3533.67
M38.963.3441.33
SIG60.663.3277.94
IBM149.243.27171.13
AZO716.173.19797.89
PDCO22.983.1443.20
ORLY299.233.00300.07
D72.002.9385.30
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 30.60
Current Ratio 33.40
Long Term Debt to Total Capital 0.31
Total Debt to Equity 0.45
Interest Coverage 171.80
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin68.60
EBITDA Margin69.20
Pre-tax Profit Margin-5 888.00
Profit Margin76.16
ValuationValueIndustryS&P 500US Markets
PE Ratio 3.90
PB Ratio 1.89
PS Ratios 2.58
Price to Cash Flow 3.90
Price to Free Cash Flow 3.50
Cash Flow Per Share 4.38
Price to Tangible Book1.89
Book Value per Share8.99
Enterprise Value (in ths.)197 805
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)10.90
ROE last 12 Months 73.23
Return on Assets (5Y Avg) 2.81
ROA last 12 Months 66.00
Return on Capital (5Y Avg) -
ROC last 12 Months 73.23
Return on invested Capital Q -2.19
Return on invested Capital Y68.40
Assets Turnover0.50
Receivables Turnover160.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)154 335
Revenue per Share 6.60
Revenue Growth 3 Years 1.31
Revenue Growth 5 Years -2.83
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.61-0.1968.85
Q04 2017-0.18-0.26-44.44
Q03 2017-0.54-0.70-29.63
Q02 2017-0.62-0.586.45
Q01 2017-0.54-0.60-11.11
Q04 2016-0.66-0.5418.18
Q03 2016-0.64-0.5120.31
Q02 2016-0.62-0.603.23
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.62-8.77Negative
9/2018 QR-0.67-13.56Negative
12/2018 FY-2.215.96Positive
12/2019 FY-2.87-19.09Negative
Next Report Date14th Aug 2018
Estimated EPS Next Report-0.62
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume65 075
Shares Outstanding (in ths.)23 400
Trades Count339
Dollar Volume844 559
Avg. Volume284 990
Avg. Weekly Volume94 377
Avg. Monthly Volume170 904
Avg. Quarterly Volume160 247

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

92%8%

Bearish Bullish

46%54%

Bearish Bullish

71%29%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x